| Lauren Reckley, MD | |
|
9300 Dewitt Loop, Fort Belvoir, VA 22060-5285 | |
| (712) 312-5445 | |
| Not Available |
| Full Name | Lauren Reckley |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Location | 9300 Dewitt Loop, Fort Belvoir, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659784759 | NPI | - | NPPES |
| VAD000 | Medicaid | HI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 18560 (Hawaii) | Secondary |
| 207Y00000X | Otolaryngology | 18560 (Hawaii) | Primary |
| Entity Name | Deaconess Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619123585 PECOS PAC ID: 3375610116 Enrollment ID: O20080922000145 |
News Archive
A team of researchers has devised a Pac-Man-style power pellet that gets normally mild-mannered cells to gobble up their undesirable neighbors. The development may point the way to therapies that enlist patients' own cells to better fend off infection and even cancer, the researchers say. A description of the work will be published July 15 in the journal Science Signaling.
During the G20 summit opening Thursday in Pittsburgh, President Obama will propose countries around the world phase out government subsidies that promote the production and use of fossil fuels "that spew carbon dioxide, the chief greenhouse gas," the Associated Press reports (Borenstein, 9/23).
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported additional clinical results for its lead product candidate, the Sufentanil NanoTab PCA System for the treatment of moderate-to-severe acute pain in the hospital setting.
Pulmonx, an emerging leader in interventional pulmonology, announced today that it has concluded an agreement for a new round of equity financing from an investment syndicate led by two new investors. The company also announced that it plans to use this capital to support the international commercial launch of its Zephyr® Endobronchial Valve (EBV), and its recently approved Chartis® Pulmonary Assessment System. Both products are CE marked and cleared for sale in Europe and other major international markets.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lauren Reckley, MD 9300 Dewitt Loop, Fort Belvoir, VA 22060-5285 Ph: (571) 231-2544 | Lauren Reckley, MD 9300 Dewitt Loop, Fort Belvoir, VA 22060-5285 Ph: (712) 312-5445 |
News Archive
A team of researchers has devised a Pac-Man-style power pellet that gets normally mild-mannered cells to gobble up their undesirable neighbors. The development may point the way to therapies that enlist patients' own cells to better fend off infection and even cancer, the researchers say. A description of the work will be published July 15 in the journal Science Signaling.
During the G20 summit opening Thursday in Pittsburgh, President Obama will propose countries around the world phase out government subsidies that promote the production and use of fossil fuels "that spew carbon dioxide, the chief greenhouse gas," the Associated Press reports (Borenstein, 9/23).
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported additional clinical results for its lead product candidate, the Sufentanil NanoTab PCA System for the treatment of moderate-to-severe acute pain in the hospital setting.
Pulmonx, an emerging leader in interventional pulmonology, announced today that it has concluded an agreement for a new round of equity financing from an investment syndicate led by two new investors. The company also announced that it plans to use this capital to support the international commercial launch of its Zephyr® Endobronchial Valve (EBV), and its recently approved Chartis® Pulmonary Assessment System. Both products are CE marked and cleared for sale in Europe and other major international markets.
› Verified 1 days ago
Jeffrey Martin Schafer, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 9300 Dewitt Loop, Atammc - Dept Of Otolaryngology, Fort Belvoir, VA 22060 Phone: 571-231-2679 | |
Charles Qiyao Yang, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 571-231-3497 | |
Dr. Scott B Roofe, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: Fort Belvoir Community Hospital, Fort Belvoir, VA 22060 Phone: 571-231-2896 | |
Dr. Colleen Frances Perez, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 571-231-2544 | |
Naomi Will, D.O. Otolaryngology Medicare: Medicare Enrolled Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 571-231-2544 | |
Dr. Charles Alexander Riley, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 571-231-3224 |